Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03130699 · ClinicalTrials.gov registry record · NA

Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes

A NA study of Diabetes Mellitus, Type 2, sponsored by Scripps Whittier Diabetes Institute.

Completed
Registry status
NA
Development phase
310
Enrollment target
2
Study locations

NCT03130699 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 310 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03130699, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Scripps Whittier Diabetes Institute.

COMPLETED
Registry status
NA
Development phase
310 participants
Enrollment target
2
Study locations

Study Summary

This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.

Conditions Studied

Diabetes Mellitus, Type 2

Interventions

  • BEHAVIORAL Dulce Digital
  • BEHAVIORAL Dulce Digital-Me (Automated Delivery)
  • BEHAVIORAL Dulce Digital-Me (Medical Assistant)

Study Locations (2)

California

  • Scripps Mercy Chula Vista - Chula Vista
  • Scripps Whittier Diabetes Institute - La Jolla

Trial Details

FieldValue
Enrollment Target 310 participants
Start Date 2017-10-31
Est. Completion 2021-08-14
Phase NA

Sponsor

Scripps Whittier Diabetes Institute

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03130699

The ClinicalTrials.gov registry entry for NCT03130699 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Dulce Digital is the first listed.

NCT03130699 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03130699 about?

NCT03130699 is a clinical study titled "Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes". This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that ...

What is the current status of trial NCT03130699?

This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2017-10-31. Estimated completion is 2021-08-14.

What conditions does trial NCT03130699 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT03130699?

The interventions under investigation include: Dulce Digital (BEHAVIORAL), Dulce Digital-Me (Automated Delivery) (BEHAVIORAL), Dulce Digital-Me (Medical Assistant) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03130699?

This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03130699 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 2

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.